Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
Retroviruses02:33

Retroviruses

12.4K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

204
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
204

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clarification to HIVMA/IDSA HIV Primary Care Guidance Immunization Recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Comorbidities and treatment regimens of HIV-associated lipodystrophy disease among a cohort of persons with HIV in Washington, DC.

AIDS care·2026
Same author

Routine collection of patient-reported outcomes in HIV clinics: lessons learned after more than 130 000 assessments have been completed.

AIDS (London, England)·2026
Same author

Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trial.

Addiction science & clinical practice·2026
Same author

Utility of the brief Patient Health Questionnaire-2 and Generalized Anxiety Disorder-2 screeners for depression and generalized anxiety symptom identification in people with human immunodeficiency virus.

HIV research & clinical practice·2026
Same author

Chronic opioid use is associated with higher antibody response to influenza vaccination in people living with HIV.

Frontiers in immunology·2026

相关实验视频

Updated: Jul 23, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K

从美国快速抗逆转录病毒疗法启动计划中学到的经验教训

Rupali K Doshi1,2, Shawnika Hull3, Aaron Broun1

  • 1Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.

International journal of STD & AIDS
|July 18, 2023
PubMed
概括

针对艾滋病毒治疗的快速抗逆转录病毒疗法启动 (R-ART) 在美国面临实施障碍. 成功的关键因素包括强有力的科学证据,利益相关者参与,以及以患者为中心的沟通,以缩短时间表.

关键词:
在CFIR中,CFIR是最重要的.艾滋病毒/艾滋病病毒/艾滋病病毒实施实施实施实施实施.质量上的影响是有质量的.治疗启动治疗启动

更多相关视频

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K

相关实验视频

Last Updated: Jul 23, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K

科学领域:

  • 实施科学 实施科学
  • 公共卫生 公共卫生
  • 传染病管理 传染病管理

背景情况:

  • 自2017年以来,建议在艾滋病毒治疗中迅速启动抗逆转录病毒疗法 (R-ART).
  • 在美国,R-ART的广泛采用仍然有限.

研究的目的:

  • 确定在美国艾滋病毒诊所实施R-ART的促进者和障碍.
  • 了解早期R-ART实施者的经验.

主要方法:

  • 使用半结构面试进行定性研究设计.
  • 以"实施研究综合框架" (CFIR) 为指导的专题分析.
  • 采访了来自美国9个早期采用艾滋病毒诊所的医疗领导层.

主要成果:

  • 对R-ART的强有力的科学依据,利益相关者的支持和缩短的时间表是关键主题.
  • CFIR的证据强度和质量构造影响了实施.
  • 通过以患者为中心的沟通和解决并发需求,患者接受缩短的时间表得到了改善.

结论:

  • 成功实施R-ART需要解决对缩短时间表的后勤规划.
  • 策略必须适应患者对艾滋病毒诊断和高药费用的各种反应.